0001209191-18-052512.txt : 20180927 0001209191-18-052512.hdr.sgml : 20180927 20180927200157 ACCESSION NUMBER: 0001209191-18-052512 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180925 FILED AS OF DATE: 20180927 DATE AS OF CHANGE: 20180927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Starling William N JR CENTRAL INDEX KEY: 0001324130 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 181092246 MAIL ADDRESS: STREET 1: 2300 BUCKSKIN ROAD CITY: POCATELLO STATE: ID ZIP: 83201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSENTERIX INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 635 DAVIS DRIVE STREET 2: SUITE 300 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-25 0 0000876378 TRANSENTERIX INC. TRXC 0001324130 Starling William N JR 345 GOLDEN HILLS DRIVE PORTOLA VALLEY CA 94028 1 0 0 0 Common Stock 2018-09-25 4 S 0 1700000 6.40 D 3618969 I See Footnote Common Stock 2018-09-26 4 S 0 775000 6.26 D 2843969 I See Footnote Common Stock 2018-09-27 4 S 0 1139649 6.13 D 1704320 I See Footnote Common Stock 235738 I See Footnote Common Stock 213415 I By Trust Common Stock 66987 D Synergy Life Science Partners, L.P., the holder of these shares, sold an aggregate of 1,700,000 shares of TransEnterix stock on September 25, 2018, an aggregate of 775,000 shares on September 26, 2018, and an aggregate of 1,139,649 shares on September 27, 2018. The reporting person is a control person of the General Partner of Synergy Life Science Partners, L.P. The reporting person disclaims any beneficial ownership of the shares of TransEnterix stock owned by Synergy Life Science Partners, L.P. and has no pecuniary interest in such shares. The sale price reported in Column 4 is a weighted average price. These shares were sold by Synergy Life Science Partners, L.P. in multiple transactions at prices ranging from $6.25 to $6.90 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The sale price reported in Column 4 is a weighted average price. These shares were sold by Synergy Life Science Partners, L.P. in multiple transactions at prices ranging from $6.20 to $6.475 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The sale price reported in Column 4 is a weighted average price. These shares were sold by Synergy Life Science Partners, L.P. in multiple transactions at prices ranging from $6.05 to $6.205 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Shares of common stock held by Synecor, LLC. The reporting person is the chief executive officer of Synecor, LLC. Shares of Common Stock held by W. Starling and D. Starling, Trustees of the Starling Family Trust, UDT August 15, 1990. /s/ Joshua Weingard, as Attorney-in-Fact for William N. Starling, Jr. 2018-09-27